Fig. 6 | Scientific Reports

Fig. 6

From: Establishing a prognostic model with immune-related genes and investigating EPHB6 expression pattern in breast cancer

Fig. 6The alternative text for this image may have been generated using AI.

EPHB6 expression in benign and cancerous breast tissues. (A-F) Representative images of benign and cancerous breast samples stained for EPHB6 expression by IHC: (A-C) invasive cancer samples were classified as weak (1+), intermediate (2+), and strong (3+). (D) In situ tumor samples with EPHB6 overexpression (Strong 3+). (E) Adjacent non-cancerous tissues with EPHB6 overexpression (Strong 3+). (F) Fibroadenoma samples with EPHB6 overexpression (Strong 3+). (G) Quantification of EPHB6 expression using integrated optical density/specimen area (IOD/area) in different breast tissues. (H-J) EPHB6 mRNA expressions in publicly available datasets: GSE21422 (H), TCGA-BRCA(I), GSE65194(J). NS, not significant; *, p < 0.05; **, p < 0.01; ***, p < 0.001.

Back to article page